SCHEMBL454941

SCHEMBL454941

O=C1C(=NNC(=S)Nc2ccc(F)cc2)Nc2ccc(F)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
GAA P10253 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MAPT P10636 3/20 0.42
KMT2A Q03164 4/20 0.42
KDR P35968 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
CA12 O43570 2/20 0.41
MAPK1 P28482 2/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
CA4 P22748 1/20 0.40
MEN1 O00255 3/20 0.40
POLB P06746 1/20 0.40
IDO1 P14902 1/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL457072 0.91 MAPT (0.47) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL455315 0.90 KDR (0.52) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL2877863 0.88 ALDH1A1 (0.46) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL13008097 0.83 KDR (0.54) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL13061438 0.78 KDR (0.51) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL31492064 0.77 KDR (0.50) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL13008032 0.77 KDR (0.50) ALDH1A1GAANPC1RAB9AMAPT
SCHEMBL457328 0.77 CES1 (0.50) ALDH1A1GAAMAPTKMT2ACA1
SCHEMBL457948 0.77 CES1 (0.47) ALDH1A1GAAMAPTKMT2AKDR
SCHEMBL31492045 0.76 LRRK2 (0.52) ALDH1A1GAAMAPTKDRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed